Vedolizumab trough:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS

Preferred Label : Vedolizumab trough:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS;

LOINC status : ACTIVE;

LOINC display name : Vedolizumab trough LC/MS/MS [Mass/Vol];

LOINC long common name : Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough;

LOINC short name : Vedolizumab Trough SerPl LC/MS/MS-mCnc;

LOINC description : Vedolizumab trough levels are measured immediately before the next scheduled dose.;

Details

Origin ID

90805-3;

UMLS CUI

C4739465;

Has challenge
- TDM Trough [LOINC Challenge]
Has component
- Vedolizumab [LOINC component]
- Vedolizumab^trough [LOINC component]
Has method
- LC/MS/MS [LOINC method]
Has property
- Mass Concentration [LOINC Property]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Vedolizumab & Vedolizumab Ab Panel:MCnc:Pt:Ser/Plas:Qn: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients